CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Dual-agent molecular targeting of growth factor receptors in hepatocellular cancer: Combining anti-EGFR antibody with an EGFR tyrosine kinase inhibitor
DOI 10.1055/s-2005-920152
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Hüther, M Höpfner, D Schuppan, H Scherübl
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Hepatocellular carcinoma (HCC) is one of the most common cancer-related causes of death worldwide. In light of the very poor 5-year-survival new therapeutic approaches are mandatory. Recently, evidence has been accumulated that the epidermal growth factor receptor (EGFR) is a promising target for cancer therapy. Several reports indicate that EGFR is expressed frequently in HCC, most likely contributing to the…
Zitieren
Zitierempfehlung
A Hüther, M Höpfner, D Schuppan, H Scherübl (2006) Dual-agent molecular targeting of growth factor receptors in hepatocellular cancer: Combining anti-EGFR antibody with an EGFR tyrosine kinase inhibitor. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-920152
Mit CareLit weiterarbeiten